Heather Waldrop, MD
Vascular Surgery · Raleigh, NCNPI 1275876393
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,455 of the $5,043 with a category attached, or 68.5%. 11 manufacturers reported payments, led by Boston Scientific at 53.7% of the total. Reporting peaked in 2023 at $2,945 and has fallen 84.5% since, to $456 in 2025.
Across 57 payments — averaging $88.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$3K
- Medtronic$1K
- W. L. Gore & Associates, Inc.$260
- Silk Road Medical, Inc.$168
- Baxter Healthcare$148
- Bolton Medical Inc$132
- plus $354 from 5 others
What the payments were for
- Travel & lodging$1,17923%
- Food & beverage$3,45569%
- Education$4088%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 26 | $2,710 |
| Medtronic(3 entities) | 16 | $1,272 |
| W. L. Gore & Associates, Inc. | 7 | $260 |
| Silk Road Medical, Inc. | 1 | $168 |
| Baxter Healthcare | 1 | $148 |
| Bolton Medical Inc | 1 | $132 |
| Cvrx, Inc. | 1 | $120 |
| Abbott | 1 | $112 |
| Cook Medical LLC | 1 | $82 |
| Terumo Medical Corporation | 1 | $22 |
| Inari Medical, Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Endurant$293
- ENDURANT IIS$256
- ENROUTE Transcarotid Stent$168
- ENROUTE Transcarotid Neuroprotection System$168
- FLOSEAL$148
- Grafts$132
- EKOSONIC$130
- Barostim Neo System$120
- ESPRIT$112
How this compares
$5,043 in reported general payments places this provider in the 60th percentile of 119 vascular surgery providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ClopidogrelClopidogrel Bisulfate | 32 | $308 |
| Rosuvastatin Calcium | 24 | $192 |
| Atorvastatin Calcium | 12 | $123 |
| Oxycodone Hcl | 15 | $91 |
Paid to pharmacies, not to this prescriber.
Other vascular surgery in Raleigh
- Robert MendesRaleigh$408K
- Ellen DillavouRaleigh$284K
- Christopher McQuinnRaleigh$77K
- Joseph SalfityRaleigh$13K
- Jason KimRaleigh$8K
- Kirk CharlesRaleigh$8K
- Liliana NanezRaleigh$7K
- Jacek PaszkowiakRaleigh$4K
- James FogartieRaleigh$3K
- Frank ArkoCharlotte$2.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.